MedPath

VIGABATRIN

These highlights do not include all the information needed to use VIGABATRIN FOR ORAL SOLUTION safely and effectively. See full prescribing information for VIGABATRIN FOR ORAL SOLUTION. VIGABATRIN for oral solutionInitial U.S. Approval: 2009

Approved
Approval ID

823cc915-0350-4780-85ed-cd1c338e429d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 10, 2022

Manufacturers
FDA

Cipla USA, Inc.

DUNS: 078719707

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vigabatrin

PRODUCT DETAILS

NDC Product Code69097-964
Application NumberANDA211592
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateApril 5, 2022
Generic Namevigabatrin

INGREDIENTS (2)

POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
VIGABATRINActive
Quantity: 500 mg in 1 mL
Code: GR120KRT6K
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VIGABATRIN - FDA Drug Approval Details